A REVIEW OF BEINCART

There are no trials of BENICAR HCT demonstrating reductions in cardiovascular chance in people with hypertension, but at least one drug pharmacologically comparable to olmesartan medoxomil has shown this kind of benefits, and hydrochlorothiazide demonstrated reduction of cardiovascular risk in clients with hypertension.Suggest clients not to employ